Behavioral Health Business December 10, 2025
New York City-based Radial announced Tuesday it raised a $50 million Series A funding round to expand its interventional psychiatry services model and underlying tech infrastructure.
The company will expand its footprint of in-network “modern brain medicine” clinics. Each will feature medication management and interventional psychiatry services such as transcranial magnetic stimulation (TMS) and rapid-acting therapeutics such as Spravato. The company also provides neuromodulation services like accelerated TMS, guided neuromodulation, and EEG biofeedback, which insurance policies do not yet widely cover.
It will also develop additional proprietary software and clinical infrastructure.
The investment giant General Catalyst led the round. Other participants included Solari Capital, JSL Health Capital, Founder Collective, BoxGroup, Scrub Capital and Diede van Lamoen.
Today, Radial operates...







